Calcitonin Salmon is Used for treating nasal conditions. It was first introduced by Sanofi Aventis Us Llc in its drug Calcimar on Approved Prior to Jan 1, 1982. Another drug containing Calcitonin Salmon is Miacalcin. 11 different companies have introduced drugs containing Calcitonin Salmon.

Calcitonin Salmon Patents

Given below is the list of patents protecting Calcitonin Salmon, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Miacalcin	US5733569	Galenic compositions comprising calcitonin and their use	Mar 31, 2015 (Expired)	Norvium Bioscience
Miacalcin	US5759565	Galenic compositions comprising calcitonin and their use	Mar 31, 2015 (Expired)	Norvium Bioscience

Add above patents to watchlist

Calcitonin Salmon's Family Patents

Full family tree

Calcitonin Salmon Generic API Manufacturers

Several generic applications have been filed for Calcitonin Salmon. The first generic version for Calcitonin Salmon was by Igi Laboratories Inc and was approved on Apr 14, 1995. And the latest generic version is by Sagent Pharmaceuticals and was approved on Jul 9, 2025.

Given below is the list of companies who have filed for Calcitonin Salmon generic, along with the locations of their manufacturing plants worldwide.